Terns Pharmaceuticals (TERN) Other Non-Current Assets (2020 - 2023)
Historic Other Non-Current Assets for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $35000.0.
- Terns Pharmaceuticals' Other Non-Current Assets fell 2553.19% to $35000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $35000.0, marking a year-over-year decrease of 2553.19%. This contributed to the annual value of $37000.0 for FY2022, which is 6063.83% down from last year.
- According to the latest figures from Q3 2023, Terns Pharmaceuticals' Other Non-Current Assets is $35000.0, which was down 2553.19% from $36000.0 recorded in Q2 2023.
- Terns Pharmaceuticals' 5-year Other Non-Current Assets high stood at $246000.0 for Q4 2020, and its period low was $35000.0 during Q3 2023.
- In the last 4 years, Terns Pharmaceuticals' Other Non-Current Assets had a median value of $68000.0 in 2022 and averaged $98916.7.
- Its Other Non-Current Assets has fluctuated over the past 5 years, first plummeted by 7218.93% in 2022, then plummeted by 2553.19% in 2023.
- Quarter analysis of 4 years shows Terns Pharmaceuticals' Other Non-Current Assets stood at $246000.0 in 2020, then crashed by 61.79% to $94000.0 in 2021, then tumbled by 60.64% to $37000.0 in 2022, then decreased by 5.41% to $35000.0 in 2023.
- Its last three reported values are $35000.0 in Q3 2023, $36000.0 for Q2 2023, and $37000.0 during Q1 2023.